Review



vegf primary antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bioss vegf primary antibody
    Vegf Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pm41787057-87-15-19?v=Bioss
    Average 94 stars, based on 37 article reviews
    vegf primary antibody - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    vegf primary antibody  (Bioss)
    94
    Bioss vegf primary antibody
    Vegf Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pm41787057-87-15-19?v=Bioss
    Average 94 stars, based on 1 article reviews
    vegf primary antibody - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    rabbit polyclonal vegf antibody  (Absolute Biotech Inc)
    86
    Absolute Biotech Inc rabbit polyclonal vegf antibody
    Rabbit Polyclonal Vegf Antibody, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pm41874073-114-33-38?v=Absolute+Biotech+Inc
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal vegf antibody - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    anti vegfr1 flt 1 antibody  (Elabscience Biotechnology)
    94
    Elabscience Biotechnology anti vegfr1 flt 1 antibody
    Anti Vegfr1 Flt 1 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pmc12999369-91-32-37?v=Elabscience+Biotechnology
    Average 94 stars, based on 1 article reviews
    anti vegfr1 flt 1 antibody - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    rabbit polyclonal anti vegf antibody  (Boster Bio)
    92
    Boster Bio rabbit polyclonal anti vegf antibody
    Rabbit Polyclonal Anti Vegf Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pm41833877-145-53-57?v=Boster+Bio
    Average 92 stars, based on 1 article reviews
    rabbit polyclonal anti vegf antibody - by Bioz Stars, 2026-08
    92/100 stars
    		  Buy from Supplier
    bs 0279r  (Bioss)
    94
    Bioss bs 0279r
    Bs 0279r, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pmc12948915-93-19-20?v=Bioss
    Average 94 stars, based on 1 article reviews
    bs 0279r - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    polyclonal anti vegf a antibody  (Santa Cruz Biotechnology)
    96
    Santa Cruz Biotechnology polyclonal anti vegf a antibody
    Polyclonal Anti Vegf A Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pm41699669-103-16-21?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    polyclonal anti vegf a antibody - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    vegfa polyclonal antibody  (Proteintech)
    96
    Proteintech vegfa polyclonal antibody
    Survival analysis of transcriptome sequencing data and clinical data of cervical cancer samples in the TCGA database. (A) The KM curves of the <t>VEGFA.</t> (B) The KM curves of the CALML3. (C) Nomogram. On the left are the diagnostic factors, each corresponding to a score. The total score is obtained by summing up the scores of all factors (Total Points), and then the survival rate is predicted based on the total score. (D) Nomogram calibration curve. The abscissa represents the predicted survival rate by the nomogram, and the ordinate represents the actual survival rate. (E) DCA curve. The horizontal axis represents the High-Risk Threshold range, and the vertical axis represents the Net Benefit. (F) ROC curve of the diagnostic model
    Vegfa Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vegf+polyclonal+antibody/pmc13013753-114-16-22?v=Proteintech
    Average 96 stars, based on 1 article reviews
    vegfa polyclonal antibody - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Survival analysis of transcriptome sequencing data and clinical data of cervical cancer samples in the TCGA database. (A) The KM curves of the VEGFA. (B) The KM curves of the CALML3. (C) Nomogram. On the left are the diagnostic factors, each corresponding to a score. The total score is obtained by summing up the scores of all factors (Total Points), and then the survival rate is predicted based on the total score. (D) Nomogram calibration curve. The abscissa represents the predicted survival rate by the nomogram, and the ordinate represents the actual survival rate. (E) DCA curve. The horizontal axis represents the High-Risk Threshold range, and the vertical axis represents the Net Benefit. (F) ROC curve of the diagnostic model

    Journal: Discover Oncology

    Article Title: Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer

    doi: 10.1007/s12672-026-04683-0

    Figure Lengend Snippet: Survival analysis of transcriptome sequencing data and clinical data of cervical cancer samples in the TCGA database. (A) The KM curves of the VEGFA. (B) The KM curves of the CALML3. (C) Nomogram. On the left are the diagnostic factors, each corresponding to a score. The total score is obtained by summing up the scores of all factors (Total Points), and then the survival rate is predicted based on the total score. (D) Nomogram calibration curve. The abscissa represents the predicted survival rate by the nomogram, and the ordinate represents the actual survival rate. (E) DCA curve. The horizontal axis represents the High-Risk Threshold range, and the vertical axis represents the Net Benefit. (F) ROC curve of the diagnostic model

    Article Snippet: The sections were allowed to incubate with a CALML3 Polyclonal antibody (1:50 dilution, 117275-1-AP, Proteintech) and VEGFA polyclonal antibody (1:50 dilution, 19003-1-AP, Proteintech) at 4 °C overnight.

    Techniques: Sequencing, Diagnostic Assay

    GSEA enrichment trend plot. (A) GSEA enrichment of VEGFA. Present only the five most enriched pathways, ordered by their enrichment score (ES), in a figure comprising three sections. The upper section illustrates the computation of the ES value. For each gene from left to right, an ES value is calculated and connected to form a line. On the leftmost side, a particularly prominent peak represents the ES value for the gene set phenotype. The middle part of the figure features each line representing a gene in the gene set and its ranking position in the gene list. The bottom part displays the matrix of gene-phenotype associations. (B) GSEA enrichment of CALML3

    Journal: Discover Oncology

    Article Title: Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer

    doi: 10.1007/s12672-026-04683-0

    Figure Lengend Snippet: GSEA enrichment trend plot. (A) GSEA enrichment of VEGFA. Present only the five most enriched pathways, ordered by their enrichment score (ES), in a figure comprising three sections. The upper section illustrates the computation of the ES value. For each gene from left to right, an ES value is calculated and connected to form a line. On the leftmost side, a particularly prominent peak represents the ES value for the gene set phenotype. The middle part of the figure features each line representing a gene in the gene set and its ranking position in the gene list. The bottom part displays the matrix of gene-phenotype associations. (B) GSEA enrichment of CALML3

    Article Snippet: The sections were allowed to incubate with a CALML3 Polyclonal antibody (1:50 dilution, 117275-1-AP, Proteintech) and VEGFA polyclonal antibody (1:50 dilution, 19003-1-AP, Proteintech) at 4 °C overnight.

    Techniques:

    Validation of CAML3 and VEGFA gene expression by IHC. (A) Immunohistochemistry analysis (IHC) staining results for normal controls and CC tissues are presented, with the top image originating from the cervical tissue of normal control and the bottom image derived from a CC patient. (B) CAML3 IHC staining reveals an increased mean density in CC whole slices compared to the normal control. (C) The IHC staining of VEGFA indicates that the average density in whole CC slices is elevated relative to the normal control. The top indicates significance. * P ≤ 0.05

    Journal: Discover Oncology

    Article Title: Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer

    doi: 10.1007/s12672-026-04683-0

    Figure Lengend Snippet: Validation of CAML3 and VEGFA gene expression by IHC. (A) Immunohistochemistry analysis (IHC) staining results for normal controls and CC tissues are presented, with the top image originating from the cervical tissue of normal control and the bottom image derived from a CC patient. (B) CAML3 IHC staining reveals an increased mean density in CC whole slices compared to the normal control. (C) The IHC staining of VEGFA indicates that the average density in whole CC slices is elevated relative to the normal control. The top indicates significance. * P ≤ 0.05

    Article Snippet: The sections were allowed to incubate with a CALML3 Polyclonal antibody (1:50 dilution, 117275-1-AP, Proteintech) and VEGFA polyclonal antibody (1:50 dilution, 19003-1-AP, Proteintech) at 4 °C overnight.

    Techniques: Biomarker Discovery, Gene Expression, Immunohistochemistry, Control, Derivative Assay